Bimini Biotech
Pre-clinicalBIMINI Biotech is a Leiden-based start-up that is developing innovative first-in-class therapeutics for oncology and autoimmune diseases by uniquely targeting the Wiskott-Aldrich-Syndrome protein
Founded
2018
Focus
Small Molecules
About
BIMINI Biotech is a Leiden-based start-up that is developing innovative first-in-class therapeutics for oncology and autoimmune diseases by uniquely targeting the Wiskott-Aldrich-Syndrome protein
Funding History
3Total raised: $25M
Series A$20MAndera PartnersSep 15, 2023
Seed$2.5MBioGeneration VenturesJun 15, 2021
Seed$2.5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2018
LocationLeiden, Netherlands
StagePre-clinical
Contact
SIMILAR COMPANIES
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile